Medicis Pharmaceutical Corp. (MRX) 34.05 0.00

Medicis Pharmaceutical Corp.
(MRX) 34.05 0.00

Last Trade:	33.46	Day Range:	33.46 - 33.46
Trade Time:	04:02PM	52wk Range:	25.15 - 40.51
Prev. Close:	33.46	Market Cap:	2.11B
Open:	0.00	Div Yield:	0.96
Volume:	0	PE:	210
EPS:	1.63

The Latest On MRX

Cantor Fitzgerald Initiates Medicis Pharma at Hold 1/27/12 7:31am

Canaccord Downgrades Medicis to Hold 1/9/12 8:53am

Bank of America Merrill Lynch Comments on Medicis Pharmaceutical 12/28/11 4:39pm

Piper Jaffray Maintains Overweight, $43 PT on Medicis Pharmaceuticals 12/28/11 8:28am

UPDATE: Deutsche Bank Maintains Buy, Lowers PT to $41 on Medicis Pharmaceuticals 12/28/11 8:11am

Financial Breakfast: Morning News Summary for December 28, 2011 12/28/11 7:31am

J.P. Morgan Maintains Overweight Rating on Medicis 12/28/11 6:58am

Goldman Sachs Lowers PT on Medicis Pharmaceutical to $38 12/28/11 5:52am

Deutsche Bank Lowers PT on Medicis Pharmaceuticals to $41 12/28/11 5:48am

Medicis Lifts Earnings Forecast 12/28/11 5:29am

Medicis Sees Q4 Revenue of $170-183M vs $189.7M Est 12/27/11 4:32pm

Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin 12/22/11 3:58am

Cantor Fitzgerald Initiates Medicis Pharma at Hold 1/27/12

Canaccord Downgrades Medicis to Hold 1/9/12

Bank of America Merrill Lynch Comments on Medicis Pharmaceutical 12/28/11

Piper Jaffray Maintains Overweight, $43 PT on Medicis Pharmaceuticals 12/28/11

UPDATE: Deutsche Bank Maintains Buy, Lowers PT to $41 on Medicis Pharmaceuticals 12/28/11

Financial Breakfast: Morning News Summary for December 28, 2011 12/28/11

J.P. Morgan Maintains Overweight Rating on Medicis 12/28/11

Goldman Sachs Lowers PT on Medicis Pharmaceutical to $38 12/28/11

Deutsche Bank Lowers PT on Medicis Pharmaceuticals to $41 12/28/11

Medicis Lifts Earnings Forecast 12/28/11

Medicis Sees Q4 Revenue of $170-183M vs $189.7M Est 12/27/11

Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin 12/22/11

Financial Breakfast: Morning News Summary for December 28, 2011 12/28/11

Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin 12/22/11

Deutsche Bank Reiterates Ratings, Price Targets On Several Pharma Firms 12/7/11

Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROE 10/24/11

Stocks to Watch for Monday 07/11/11: Fresh 52 Week Highs and Lows 7/10/11

Medicis Pharmaceutical Hits 52-Week High (MRX) 4/8/11

Cramer Talks About The Best Of Breed Stocks AGN, MRX, TIF, COH, MO, PMI, WYNN, LVS, BUD 9/10/10

Stocks Rising On Strong Volume (MRX, MELI, LFL) 8/6/10

Calls Purchased on Medicis Pharma (MRX) 7/20/10

Calls Purchased on Medicis Pharma (MRX) 6/21/10

Calls Sold on Medicis Pharma (MRX) 6/10/10

Top 5 Small-Cap Stocks In The Biotechnology Industry With The Highest Return On Equity (OMPI, MRX, AOB, EBS, SSRX) 6/3/10

Cantor Fitzgerald Initiates Medicis Pharma at Hold 1/27/12

Canaccord Downgrades Medicis to Hold 1/9/12

Bank of America Merrill Lynch Comments on Medicis Pharmaceutical 12/28/11

Piper Jaffray Maintains Overweight, $43 PT on Medicis Pharmaceuticals 12/28/11

UPDATE: Deutsche Bank Maintains Buy, Lowers PT to $41 on Medicis Pharmaceuticals 12/28/11

Financial Breakfast: Morning News Summary for December 28, 2011 12/28/11

J.P. Morgan Maintains Overweight Rating on Medicis 12/28/11

Goldman Sachs Lowers PT on Medicis Pharmaceutical to $38 12/28/11

Deutsche Bank Lowers PT on Medicis Pharmaceuticals to $41 12/28/11

Deutsche Bank Reiterates Ratings, Price Targets On Several Pharma Firms 12/7/11

UPDATE: Canaccord Reiterates Buy, Lowers Target to $43 on Medicis 12/6/11

UPDATE: Deutsche Bank Maintains Buy, Raises Target to $44 on Medicis Pharma 12/6/11

Trade MRX
NOW!

Partner Headlines

Solta's LIPOSONIX Reaches the U.S. - Analyst Blog 1/13/12

Solta Medical Backs 4Q View - Analyst Blog 1/12/12

Stocks You Can Buy at Cheaper Prices Than Eveillard Did 1/9/12

Medicis Cuts Fourth Quarter View - Analyst Blog 12/29/11

Medicis Pharmaceuticals 12/27/11

Medicis Eyes Graceway Pharma - Analyst Blog 11/25/11

Medicis Misses Zacks Consensus - Analyst Blog 11/11/11

Medicis May Not Stay Independent (MRX, VRX, AGN, JNJ, WCRX, TEVA, SLTM, IPXL, MYL) 11/10/11

Solta Closes Medicis Unit Buy - Analyst Blog 11/7/11

Solta Reports LipoSonix Approval - Analyst Blog 10/27/11

Solta Buying Medicis Unit - Analyst Blog 9/15/11

Press Releases

Critical Alerts For GE, NVIDIA, Encana, Kinross Gold, and Medicis Pharmaceutical Released by Seven Summits Research 1/24/12 Newswire Story

THE Aesthetic Show(TM) Announces Open Submissions for Second Annual THE Aesthetic Awards(TM), Honoring the Best in Aesthetic Medicine 1/9/12 GlobeNewswire Story

Medicis to Present at J.P. Morgan Healthcare Conference 1/5/12 GlobeNewswire Story

Medicis Provides Updates on Its Corporate Initiatives 12/27/11 GlobeNewswire Story

Medicis Declares Cash Dividend 12/14/11 GlobeNewswire Story

Medicis Announces Close of Graceway Acquisition 12/2/11 GlobeNewswire Story

Medicis to Present at Piper Jaffray Health Care Conference 11/23/11 GlobeNewswire Story

Winners Announced at THE Aesthetic Awards(TM) Miami, Co-Presented by New You Magazine 11/20/11 GlobeNewswire Story

Medicis Wins Auction for Graceway Pharmaceuticals 11/18/11 GlobeNewswire Story

Critical Alerts for Merck, du Pont, Union Pacific, Express Scripts, and Medicis Pharmaceutical Released by Seven Summits Research 11/10/11 Newswire Story

Medicis Reports Third Quarter 2011 Results 11/8/11 GlobeNewswire Story

Medicis to Present at Credit Suisse 2011 Healthcare Conference 11/7/11 GlobeNewswire Story

Get the latest MRX stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Medicis Pharmaceutical Corp. stock price.

Medicis Pharmaceutical Corp. by YCharts